CAMP — CAMP4 THERAPEUTICS CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying CAMP?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their CAMP position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).
- +1 tracked investors reported holding CAMP at their latest filing
- +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
- −2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.
About CAMP4 THERAPEUTICS CORP (CAMP)
CAMP4 THERAPEUTICS CORP (CAMP) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1M. Across recent filings, tracked investors recorded 2 new positions, 1 increased, 2 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CAMP
How many top investors track CAMP
Only 1 tracked investor report this position.
CAMP Ownership Composition
How CAMP4 THERAPEUTICS CORP is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting CAMP
2 tracked investors have since exited this position — listed separately below.
- Izzy EnglanderJun 30, 2026Millennium ManagementShares43.9KValue$191.9K% Portfolio0.00%
Previously held CAMP
These investors reported CAMP in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Ken Griffin | Citadel Advisors | 200K | $1M | Dec 31, 2024 |
| Steve Cohen | Point72 Asset Management | 17.3K | $76.4K | Mar 31, 2026 |
Recent activity
- $192.9KAug 14, 2025
- Reduced$61.9K(-89.37%)Feb 17, 2026
- Increased$378.9K(750.50%)May 15, 2026
- Reduced$191.9K(-48.90%)Aug 14, 2026
- Sold$0(-100.00%)May 15, 2025
- New$76.4KMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
Frequently asked questions
- How many institutional investors hold CAMP?
- 1 tracked institutional investor disclosed a position in CAMP (CAMP4 THERAPEUTICS CORP) in their most recent 13F filing.
- Who is the largest institutional holder of CAMP?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in CAMP, valued at $1M.
- Did institutional ownership of CAMP increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 1 increased, 2 reduced, and 2 fully exited CAMP.
- Where does this CAMP ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.